Percentage of participants reaching PASI 75 · psoriasis
Dietary intervention may leads to higher severity of psoriasis PASI 75 (the proportion of participants… compared with usual care (low certainty).
1 finding from 1 review
Change in BMI · psoriasis
1 finding from 1 review
Participant adherence to intervention · psoriasis
Dietary intervention showed no clear difference in adherence to the intervention compared with usual care (low certainty).
1 finding from 1 review
Change in DLQI score (LOCF) · psoriasis
1 finding from 1 review
Time to relapse Not measured · psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in BMI · psoriasis
1 finding from 1 review
Percentage of participants reaching PASI 75 · psoriasis
Dietary intervention and exercise programme showed no clear difference in severity of psoriasis PASI 75 (the proportion of participants… compared with information only (moderate certainty).
1 finding from 1 review
Participant adherence to intervention · psoriasis
Dietary intervention and exercise programme showed no clear difference in adherence to the intervention compared with information only (moderate certainty).
1 finding from 1 review
Quality of life Not measured · psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to relapse Not measured · psoriasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pruritus · children with eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: clinical flare · adults with eczema
1 finding from 1 review
Pruritus · adults with eczema
1 finding from 1 review
Primary outcome 2. Proportion of participants reporting adverse effects and serious adverse events throughout the study period · adults with eczema
Fexofenadine 120 mg/d showed no clear difference in primary outcome 2. Proportion of participants reporting adverse… compared with placebo (1‐week intervention) (moderate certainty).
1 finding from 1 review
Secondary outcome 1. Mean change in physician‐assessed clinical signs This outcome was assessed as investigator‐assessed change in the ratio of pruritus area to body surface area · adults with eczema
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Moderate
Secondary outcome: quality of life · adults with eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome 3. Number of eczema flares, measured by, for example, ‘escalation of treatment’ or ‘use of topical anti‐inflammatory medications’ Amount of 0.1% hydrocortisone butyrate cream used during the study · adults with eczema
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Moderate
Pruritus · adults with eczema
1 finding from 1 review
Primary outcome 2. Proportion of participants reporting adverse effects and serious adverse events throughout the study period · adults with eczema
Loratadine 10 mg/d showed no clear difference in primary outcome 2. Proportion of participants reporting adverse… compared with placebo (4‐week intervention) (low certainty).
1 finding from 1 review
Physician‐assessed changes in clinical signs · adults with eczema
1 finding from 1 review